AWM Investment Company’s RAPT Therapeutics RAPT Stock Holding History

AWM Investment Company’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-162,560	Closed	-$5.51M	–	110
2025 Q4	$5.51M	Buy	+162,560	New	+$5.05M	0.53%	53

AWM Investment Company's RAPT Position: Q1 2026 in Review

AWM Investment Company sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 162,560 shares — an estimated $5.51M sold.

AWM Investment Company first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $5.51M in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

AWM Investment Company reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
AWM Investment Company sold 162,560 RAPT Therapeutics shares in Q1 2026, an estimated $5.51M.
AWM Investment Company first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
AWM Investment Company's RAPT Therapeutics position peaked at $5.51M in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.